-
Comparison of well-differentiated gastroenteropancreatic grade 3 neuroendocrine tumors (G3NETS): de novo and in the setting of apparent grade progression over time. Endocrine Abstracts. 2023 Dec 15.
Khuong KL, Paciorek PA, Moon MF, Lawhn LH, Hope HT, Fidelman FN, Mulvey MC, Lindsay LS, Zhang¬ ZL, Nakakura NE, Joseph JN, Bergsland BE. .
View in:
Publisher Site Mentions:
-
Rising incidence of bronchopulmonary neuroendocrine tumors. Endocrine Abstracts. 2023 Dec 15.
Paciorek PA, Moon MF, Khuong KL, Zhang ZL, Steiding SP, Bergsland BE, Mulvey MC. .
View in:
Publisher Site Mentions:
-
Quality of life differs by age and sex for participants with advanced neuroendocrine neoplasms in the eNET study. Endocrine Abstracts. 2023 Dec 15.
Mulvey MC, Paciorek PA, Steiding SP, Moon MF, Zhang ZL, Bergsland BE. .
View in:
Publisher Site Mentions:
-
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Correction: Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report. Cardiooncology. 2023 Nov 29; 9(1):43.
Patel K, Hsu KY, Lou K, Soni K, Lee YJ, Mulvey CK, Baik AH. PMID: 38031204; PMCID: PMC10685548.
View in:
PubMed Mentions:
-
Emerging Precision Medicine Approaches for Lung Neuroendocrine Tumors. Cancers (Basel). 2023 Nov 25; 15(23).
Mulvey CK. PMID: 38067279; PMCID: PMC10705103.
View in:
PubMed Mentions:
-
Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report. Cardiooncology. 2023 Oct 31; 9(1):38.
Patel K, Hsu KY, Lou K, Soni K, Lee YJ, Mulvey CK, Baik AH. PMID: 37908018; PMCID: PMC10617075.
View in:
PubMed Mentions:
1
-
Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas. Br J Cancer. 2023 08; 129(2):291-300.
Raj N, Chan JA, Wang SJ, Aggarwal RR, Calabrese S, DeMore A, Fong L, Grabowsky J, Hope TA, Kolli KP, Mulvey CK, Munster PN, Perez K, Punn S, Reidy-Lagunes D, Von Fedak S, Zhang L, Bergsland EK. PMID: 37208512; PMCID: PMC10338510.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansCTClinical Trials
-
Feasibility of e-NET: A Web-Based Health Platform to Investigate Quality of Life in Patients with Neuroendocrine Tumors. Endocrine Abstracts. 2023 Feb 1.
Mulvey MC, Steiding SP, Moon MF, Paciorek PA, Zhang ZL, Bergsland BE. .
View in:
Publisher Site Mentions:
-
Checkpoint Inhibitor Immunotherapy to Treat Temozolomide-Associated Hypermutation in Advanced Atypical Carcinoid Tumor of the Lung. JCO Precis Oncol. 2022 06; 6:e2200009.
Sun F, Grenert JP, Tan L, Van Ziffle J, Joseph NM, Mulvey CK, Bergsland E. PMID: 35737914; PMCID: PMC9249272.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Got Stage Fright? A Fellow-Led Initiative to Improve Cancer Staging Documentation. . 2021 Nov 5.
Brondfield BS, Mulvey MC, Banerjee BR, Velazquez VA, Kambhampati KS, Parks PA, Griffin GA, Cinar CP. .
View in:
Publisher Site Mentions:
-
Abstract A108: Differences in incidence by sex and race/ethnicity of adrenocortical carcinomas and malignant pheochromocytomas and paragangliomas in California. Cancer Epidemiology Biomarkers & Prevention. 2020 Jun 1; 29(6_Supplement_2):a108-a108.
Mulvey MC, Paciorek PA, Shih SB, McKinley MM, Pearson PD, Cheng CI, Zhang ZL, Griffin GA, Duh DQ, Roman RS, Sosa SJ, Suh SI, Liu LC, Van Loon VK, Bergsland BE. .
View in:
Publisher Site Mentions:
-
Abstract D111: Incidence and survival patterns of gastroenteropancreatic neuroendocrine neoplasms in California. Cancer Epidemiology Biomarkers & Prevention. 2020 Jun 1; 29(6_Supplement_2):d111-d111.
Paciorek PA, Shih SB, McKinley MM, Cheng CI, Zhang ZL, Mulvey MC, Griffin GA, Nakakura NE, Duh DQ, Suh SI, Van Loon VK, Bergsland BE. .
View in:
Publisher Site Mentions:
-
Got stage fright? A fellow-led initiative to improve cancer staging documentation. Journal of Clinical Oncology. 2019 Sep 20; 37(27_suppl):310-310.
Velazquez Manana VA, Banerjee BR, Kambhampati KS, Parks PA, Brondfield BS, Mulvey MC, Cinar CP. .
View in:
Publisher Site Mentions:
-
View in:
PubMed Mentions:
11 Fields:
Translation:
Humans
-
Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part A (pembrolizumab alone). Journal of Clinical Oncology. 2019 Feb 1; 37(4_suppl):363-363.
Mulvey MC, Raj RN, Chan CJ, Aggarwal AR, Cinar CP, Hope HT, Kolli KK, Zhang ZL, Calabrese CS, Grabowsky GJ, Modarresi ML, Kelly KV, Stonely SD, Munster MP, Reidy RD, Fong FL, Bergsland BE. .
View in:
Publisher Site Mentions:
-
Incidence patterns of neuroendocrine neoplasms in California. Journal of Clinical Oncology. 2019 Feb 1; 37(4_suppl):242-242.
Paciorek PA, Shih SB, McKinley MM, Cheng CI, Zhang ZL, Mulvey MC, Griffin GA, Van Loon VK, Bergsland BE. .
View in:
Publisher Site Mentions:
-
Implementation of a fellow-initiated financial toxicity screening tool in medical oncology clinics. Journal of Clinical Oncology. 2018 Oct 20; 36(30_suppl):64-64.
Brondfield BS, Borno BH, Mulvey MC, Huang HL, Cinar CP. .
View in:
Publisher Site Mentions:
-
Progress in the Evaluation and Treatment of Small Bowel Neuroendocrine Tumors. J Oncol Pract. 2018 08; 14(8):487-489.
Mulvey CK, Bergsland EK. PMID: 30096272.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Periprocedural management of patients undergoing liver resection or liver-directed therapy for neuroendocrine tumor metastases. Journal of Clinical Oncology. 2017 May 20; 35(15_suppl):e15689-e15689.
Kwon KD, Mulvey MC, Paciorek PA, Chan CH, Meng ML, Zhang ZL, Nakakura NE, Fidelman FN, Bergsland BE, Van Loon VK. .
View in:
Publisher Site Mentions:
-
Complicated Case Presentation: Management of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1. Pancreas. 2017 03; 46(3):416-426.
Mulvey CK, Van Loon K, Bergsland EK, Masharani U, Nakakura EK. PMID: 28187108.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Selective association of electrocardiographic abnormalities with insulin sensitivity and beta-cell function in type 2 diabetes mellitus: a cross-sectional analysis. Diabetes Metab Res Rev. 2016 10; 32(7):736-744.
Bhatt AB, Mulvey CK, Qasim AN, Nair JV, Rickels MR, Prenner SB, Iqbal N, Reilly MP. PMID: 26889668; PMCID: PMC5764080.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansCells
-
Systemic Therapies for Advanced Gastrointestinal Carcinoid Tumors. Hematol Oncol Clin North Am. 2016 Feb; 30(1):63-82.
Mulvey CK, Bergsland EK. PMID: 26614369.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Ascending and descending thoracic aorta calcification in type 2 diabetes mellitus. J Cardiovasc Comput Tomogr. 2015 Sep-Oct; 9(5):373-81.
Churchill TW, Rasania SP, Rafeek H, Mulvey CK, Terembula K, Ferrari V, Jha S, Lilly SM, Eraso LH, Reilly MP, Qasim AN. PMID: 26119363.
View in:
PubMed Mentions:
12 Fields:
Translation:
Humans
-
Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides. Atherosclerosis. 2014 Oct; 236(2):244-50.
Prenner SB, Mulvey CK, Ferguson JF, Rickels MR, Bhatt AB, Reilly MP. PMID: 25105581; PMCID: PMC4209900.
View in:
PubMed Mentions:
22 Fields:
Translation:
Humans
-
Omega-3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers. Mol Nutr Food Res. 2014 Mar; 58(3):601-13.
Ferguson JF, Mulvey CK, Patel PN, Shah RY, Doveikis J, Zhang W, Tabita-Martinez J, Terembula K, Eiden M, Koulman A, Griffin JL, Mehta NN, Shah R, Propert KJ, Song WL, Reilly MP. PMID: 24190860; PMCID: PMC3947472.
View in:
PubMed Mentions:
19 Fields:
Translation:
Humans
-
Differential associations of oral glucose tolerance test-derived measures of insulin sensitivity and pancreatic β-cell function with coronary artery calcification and microalbuminuria in type 2 diabetes. Diabetes Care. 2014; 37(1):124-33.
Mulvey CK, McNeill AM, Girman CJ, Churchill TW, Terembula K, Ferguson JF, Shah R, Mehta NN, Qasim AN, Rickels MR, Reilly MP. PMID: 23949560; PMCID: PMC3867998.
View in:
PubMed Mentions:
10 Fields:
Translation:
HumansCells
-
Non-compressible arterial disease and the risk of coronary calcification in type-2 diabetes. Atherosclerosis. 2013 Sep; 230(1):17-22.
Lilly SM, Qasim AN, Mulvey CK, Churchill TW, Reilly MP, Eraso LH. PMID: 23958247.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Abstract 84: Serum Amyloid A Does Not Modulate the Inverse Association of HDL with Coronary Artery Calcification in Type 2 Diabetes. Arteriosclerosis Thrombosis and Vascular Biology. 2013 May 1; 33(suppl_1).
Mulvey MC, Churchill CT, Terembula TK, Ferguson FJ, Mehta MN, Qasim QA, Reilly RM. .
View in:
Publisher Site Mentions:
-
Abstract 416: Baseline Electrocardiographic Findings Are Associated With Insulin Sensitivity and Beta-Cell Function in Type 2 Diabetes. Arteriosclerosis Thrombosis and Vascular Biology. 2013 May 1; 33(suppl_1).
Bhatt BA, Mulvey MC, Qasim QA, Rickels RM, Nair NJ, Reilly RM. .
View in:
Publisher Site Mentions:
-
Race and gender variation in response to evoked inflammation. J Transl Med. 2013 Mar 12; 11:63.
Ferguson JF, Patel PN, Shah RY, Mulvey CK, Gadi R, Nijjar PS, Usman HM, Mehta NN, Shah R, Master SR, Propert KJ, Reilly MP. PMID: 23497455; PMCID: PMC3636014.
View in:
PubMed Mentions:
61 Fields:
Translation:
Humans
-
Cardiovascular risk factors and mitral annular calcification in type 2 diabetes. Atherosclerosis. 2013 Feb; 226(2):419-24.
Qasim AN, Rafeek H, Rasania SP, Churchill TW, Yang W, Ferrari VA, Jha S, Master SM, Mulvey CK, Terembula K, Dailing C, Budoff MJ, Kawut SM, Reilly MP. PMID: 23273961; PMCID: PMC3568504.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Peroxisome Proliferator-Activated Receptor-α Agonism With Fenofibrate Does Not Suppress Inflammatory Responses to Evoked Endotoxemia. J Am Heart Assoc. 2012 Aug; 1(4):e002923.
Mulvey CK, Ferguson JF, Tabita-Martinez J, Kong S, Shah RY, Patel PN, Master SR, Usman MH, Propert KJ, Shah R, Mehta NN, Reilly MP. PMID: 23130172; PMCID: PMC3487364.
View in:
PubMed Mentions:
8 Fields:
-
Abstract 462: Dose Matters: Omega-3 Polyunsaturated Fatty Acid Supplementation at 3600 mg/d but Not 900 mg/d Reduces Inflammatory Response to Evoked Endotoxemia in Healthy Volunteers. Arteriosclerosis Thrombosis and Vascular Biology. 2012 May 1; 32(suppl_1).
Ferguson FJ, Mulvey MC, Shah SR, Patel PP, Kong KS, Tabita-Martinez TJ, Terembula TK, Mehta MN, Shah SR, Reilly RM. .
View in:
Publisher Site Mentions:
-
Abstract 482: Peroxisome Proliferator-Activated Receptor a Modulation with Fenofibrate Does Not Alter the Clinical or Inflammatory Responses to Evoked Endotoxemia in Humans. Arteriosclerosis Thrombosis and Vascular Biology. 2012 May 1; 32(suppl_1).
Mulvey MC, Ferguson FJ, Terembula TK, Tabita-Martinez TJ, Shah SR, Patel PP, Usman UM, Shah SR, Mehta MN, Rader RD, Reilly RM. .
View in:
Publisher Site Mentions:
-
DIFFERENTIAL RELATIONS OF BASELINE AND ENDOTOXIN-INDUCED SERUM AMYLOID A LEVELS IN HUMANS. Journal of the American College of Cardiology. 2012 Mar 1; 59(13):e1780.
Mulvey MC, Mehta MN, Usman UM, Master MS, Shah SR, Patel PP, hinkle hC, Shah SR, Ferguson FJ, Reilly RM. .
View in:
Publisher Site Mentions:
-
QUANTITATIVE ASSESSMENT OF MITRAL ANNULAR CALCIFICATION BY CARDIAC CT IN A DIABETIC POPULATION: ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS AND CORONARY ARTERY CALCIUM. Journal of the American College of Cardiology. 2012 Mar 1; 59(13):e1194.
Rafeek RH, Rasania RS, Churchill CT, Mulvey MC, Ferrari FV, Jha JS, Terembula TK, Reilly RM, Qasim QA, Kawut KS. .
View in:
Publisher Site Mentions:
-
CALCIFICATION OF THE ASCENDING AND DESCENDING THORACIC AORTA IDENTIFIES TWO DISTINCT PHENOTYPES IN TYPE 2 DIABETES. Journal of the American College of Cardiology. 2012 Mar 1; 59(13):e1675.
Churchill CT, Rafeek RH, Rasania RS, Mulvey MC, Ferrari FV, Jha JS, Terembula TK, Lilly LS, Eraso EL, Reilly RM, Qasim QA. .
View in:
Publisher Site Mentions: